Characteristic | Entire Group(n=68) | CAD *(n=20) | No CAD(n=48) | P |
---|---|---|---|---|
Age (yrs) | 66.4±8.8 | 70.8±5.9 | 64.5±9.2 | 0.001 |
CAD risk factors | ||||
Diabetes | 16 (24%) | 5 (25%) | 11 (23%) | 0.85 |
Hypertension | 45 (66%) | 16 (80%) | 29 (60%) | 0.12 |
Cigarette smoking | 21 (30%) | 5 (25%) | 16 (33%) | 0.50 |
Hyperlipidemia | 41 (60%) | 18 (90%) | 23 (48%) | 0.001 |
Family history of CAD | 33 (49%) | 9 (45%) | 24 (50%) | 0.71 |
Menopause | 66 (97%) | 20 (100%) | 46 (96%) | 0.35 |
Obesity (BMI ≥ 30 kg/m 2 ) | 19 (28%) | 6 (30%) | 13 (27%) | 0.81 |
Number of risk factors | 3.5±1.4 | 4.0±1.2 | 3.4±1.5 | 0.13 |
Rose chest pain questionnaire | ||||
Angina | 41 (61%) | 13 (68%) | 28 (58%) | 0.45 |
Medications | ||||
Statins | 20 (29%) | 8 (40%) | 12 (25%) | 0.22 |
Beta-blockers | 35 (51%) | 14 (70%) | 21 (44%) | 0.05 |
Aspirin | 43 (63%) | 15 (75%) | 28 (58%) | 0.19 |
ACE-inhibitors | 27 (40%) | 8 (40%) | 19 (40%) | 0.97 |
Nitrates | 7 (10%) | 2 (10%) | 5 (10%) | 1.00†† |
Diuretics | 19 (28%) | 3 (15%) | 16 (33%) | 0.12 |
Hormone replacement† | 32 (48%) | 8 (40%) | 24 (52%) | 0.41 |
Blood tests ‡ | ||||
Fasting glucose (mg/dL) | 99.3±16.6 | 101.7±15.6 | 98.4±17.1 | 0.52 |
Lipids | ||||
Total cholesterol (mg/dL) | 225.3±36.8 | 237.6±33.8 | 220.2±37.2 | 0.08 |
LDL (mg/dL) | 137.0±32.5 | 147.3±28.5 | 132.7±33.4 | 0.09 |
HDL (mg/dL) | 59.8±16.8 | 59.9±19.6 | 59.7±15.6 | 0.97 |
Triglycerides (mg/dL) | 146.7±70.0 | 152.3±71.1 | 144.4±70.2 | 0.68 |
hs-CRP (mg/dL) | 0.36±0.5 | 0.48±0.7 | 0.32±0.4 | 0.35 |
Indication for angiography | ||||
Positive stress nuclear study | 9 (13%) | 5 (25%) | 4 (8%) | |
Positive stress echo study | 6 (9%) | 3 (15%) | 3 (6%) | |
Positive treadmill ECG study | 39 (57%) | 9 (45%) | 30 (63%) | |
Clinical symptoms alone | 14 (21%) | 3 (15%) | 11 (23%) | |
12-lead ECG | ||||
Q-wave || | 5 (7%) | 1 (5%) | 4 (8%) | 1.00†† |
RBBB # | 2 (3%) | 1 (5%) | 1 (2%) | 1.00†† |